Welcome to LookChem.com Sign In|Join Free

CAS

  • or

58662-84-3

Post Buying Request

58662-84-3 Suppliers

Recommended suppliersmore

This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.

58662-84-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 58662-84-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,8,6,6 and 2 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 58662-84:
(7*5)+(6*8)+(5*6)+(4*6)+(3*2)+(2*8)+(1*4)=163
163 % 10 = 3
So 58662-84-3 is a valid CAS Registry Number.
InChI:InChI=1/C16H12ClN3O3/c1-9-16(21)19-14-7-6-10(20(22)23)8-12(14)15(18-9)11-4-2-3-5-13(11)17/h2-9H,1H3,(H,19,21)/t9-/m0/s1

58662-84-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name (3S)-5-(2-chlorophenyl)-3-methyl-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one

1.2 Other means of identification

Product number -
Other names Meclonazepam [INN]

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:58662-84-3 SDS

58662-84-3Downstream Products

58662-84-3Relevant articles and documents

Benzodiazepine derivatives and their pharmaceutical use

-

, (2008/06/13)

There are presented novel pharmaceutically active substances which inhibit the intestinal resorption of cholesterol and which accordingly can be used in the control or prevention of atherosclerosis. These active substances are benzodiazepines of the formu

Benzodiazepine derivatives

-

, (2008/06/13)

This invention is directed to pharmacologically active compounds of the formula STR1 wherein R1 represents a hydrogen atom or lower alkyl group and R2 represents a halogen atom. The compounds of formula I are optically active and have the absolute configuration S at the carbon atom in the 3-position. They exhibit anthelmintic, sedative, anticonvulsant and muscle relaxant activity. Also provided are methods for their preparation and formulations which incorporate the active compounds.